Search

Search Results
Results 71 - 80 of 571 for Abnormal
  • Nevirapine Viatris
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Nevirapine Viatris intended for persons living in Australia.
  • Celsentri
    Drug - 11 Nov 2022
    Consumer Medicine Information (CMI) about Celsentri intended for persons living in Australia.
  • Proveblue
    Drug - 27 Oct 2022
    Consumer Medicine Information (CMI) about Proveblue intended for persons living in Australia.
  • Lumakras
    Drug - 14 Jun 2022
    Consumer Medicine Information (CMI) about Lumakras intended for persons living in Australia.
  • Betmiga
    Drug - 21 Jul 2021
    Consumer Medicine Information (CMI) about Betmiga intended for persons living in Australia.
  • Actrapid, Protaphane, Mixtard 30/70
    Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about Actrapid, Protaphane, Mixtard 30/70 intended for persons living in Australia.
  • Ryzodeg 70/30 Penfill
    Drug - 4 Dec 2025
    Consumer Medicine Information (CMI) about Ryzodeg 70/30 Penfill intended for persons living in Australia.
  • Actrapid Vial, Protaphane Vial
    Drug - 1 Dec 2025
    Consumer Medicine Information (CMI) about Actrapid Vial, Protaphane Vial intended for persons living in Australia.
  • Mabcampath
    Drug - 18 May 2026
    Consumer Medicine Information (CMI) about Mabcampath intended for persons living in Australia.
  • Malarone
    Drug - 5 May 2026
    Consumer Medicine Information (CMI) about Malarone intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback